Study guide

9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid

Overseas Registration Examination ORE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: ORE Part 1 — Exam Blueprint, Logistics and Strategy

1.1 Structure and Format of ORE Part 1 1.2 The Official Blueprint and Preparing for Practice 1.3 Eligibility, Fees, Attempts and Time Limits

2 Chapter 2: Anatomy of the Head and Neck

2.1 The Trigeminal Nerve and Dental Innervation 2.2 The Facial Nerve and Parotid Region 2.3 The Temporomandibular Joint and Muscles of Mastication 2.4 The Infratemporal Fossa and Spread of Odontogenic Infection

3 Chapter 3: Dental Anatomy, Morphology and Occlusion

3.1 Permanent and Primary Tooth Morphology 3.2 Functional Occlusion: Centric Relation, Guidance and Interferences 3.3 Classifying Occlusion: Angle and BSI Incisor Relationships

4 Chapter 4: Genetics, Embryology and Odontogenesis

4.1 Stages of Odontogenesis and Molecular Signalling 4.2 Amelogenesis and Enamel Microstructure 4.3 Dentinogenesis and the Pulp-Dentine Complex 4.4 Cementum, the Periodontal Ligament and Oral Mucosa 4.5 Genetic and Developmental Dental Anomalies

5 Chapter 5: Oral Biology and Salivary Physiology

5.1 Salivary Gland Anatomy, Microarchitecture and Innervation 5.2 Salivary Secretion, Flow Rates and Autonomic Control 5.3 Salivary Buffering Systems and Protective Macromolecules 5.4 Physiology of Mastication and Deglutition 5.5 Taste, Lingual Papillae and Gustatory Pathways 5.6 Xerostomia, Sjogren's Syndrome and Salivary Diagnostics

6 Chapter 6: Physiology of the Major Body Systems

6.1 Cardiovascular and Respiratory Physiology 6.2 Renal, Endocrine and Gastrointestinal Physiology 6.3 Haematology and Haemostasis 6.4 Neurophysiology, Pain and the Autonomic Nervous System

7 Chapter 7: Bone Biology, Calcium Homeostasis and Healing

7.1 Microstructure and Architecture of Alveolar Bone 7.2 Bone Remodelling and the RANK/RANKL/OPG Axis 7.3 Endocrine Control of Calcium and Phosphate 7.4 Extraction Socket Healing and Ridge Resorption 7.5 Impaired Healing: MRONJ, Osteoradionecrosis and Systemic Risk

8 Chapter 8: Oral Microbiology and Biofilm Ecology

8.1 The Oral Microbiome and Biofilm Development 8.2 Cariogenic Microbiology: Mutans Streptococci and Lactobacilli 8.3 Ecological Hypotheses of Dental Caries 8.4 Biofilm Tolerance and the Case for Mechanical Plaque Control

9 Chapter 9: Immunology Relevant to Oral Disease

9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid 9.2 Cellular Immunity in the Periodontium 9.3 Microbial Pathogenesis: Complexes and Keystone Pathogens 9.4 Host-Mediated Tissue Destruction 9.5 Hypersensitivity Reactions in Dental Practice 9.6 Autoimmune Mucocutaneous Bullous Disease 9.7 Immunodeficiency and Oral HIV Manifestations

10 Chapter 10: General Pathology and Neoplasia

10.1 Cellular Adaptation and Mechanisms of Cell Death 10.2 Inflammation, Wound Healing and Repair 10.3 Principles of Neoplasia and Carcinogenesis 10.4 TNM Staging of Oral Cavity Carcinoma

11 Chapter 11: Statistics and Research Methods

11.1 Study Designs and the Hierarchy of Evidence 11.2 Descriptive and Inferential Statistics 11.3 Diagnostic Test Performance 11.4 Critical Appraisal, Bias and Research Governance

12 Chapter 12: Human Disease: Cardiovascular and Respiratory

12.1 Infective Endocarditis and NICE CG64 12.2 Hypertension and Blood Pressure Thresholds for Dental Care 12.3 Angina, Myocardial Infarction and Antiplatelet Therapy 12.4 Asthma, COPD and Respiratory Emergencies

13 Chapter 13: Human Disease: Endocrine, Haematological and Renal

13.1 Diabetes Mellitus and the Periodontal Axis 13.2 Congenital Bleeding and Clotting Disorders 13.3 Anticoagulants and Antiplatelets: The SDCEP Protocol 13.4 Chronic Kidney Disease and Haemodialysis

14 Chapter 14: Human Disease: Gastrointestinal, Hepatic and Neurological

14.1 Gastrointestinal Disease and Intrinsic Dental Erosion 14.2 Liver Disease, Coagulopathy and Viral Hepatitis 14.3 Epilepsy, Stroke and Transient Ischaemic Attack 14.4 Trigeminal Neuralgia, Bell's Palsy and Giant Cell Arteritis

15 Chapter 15: Oral Aspects of Human Disease

15.1 Oral Manifestations of Systemic Disease 15.2 Orofacial Pain and Temporomandibular Disorders 15.3 Dry Mouth, Altered Taste and Halitosis

16 Chapter 16: Infection Prevention and Control

16.1 The Decontamination Cycle, Sterilization and Waterlines 16.2 Routes of Transmission and Blood-Borne Viruses

17 Chapter 17: Dental Materials

17.1 Dental Amalgam: Metallurgy and UK Regulation 17.2 Resin Composites: Chemistry and Placement 17.3 Dental Adhesive Systems 17.4 Acid Etching, the Hybrid Layer and MMP Degradation 17.5 Glass Ionomer Cements, RMGICs and Compomers 17.6 Impression Materials and Digital Scanning 17.7 Luting Cements and Adhesive Conditioning Protocols 17.8 Dental Ceramics and Cast Alloys 17.9 Gypsum Products, Waxes and Denture Base Polymers

18 Chapter 18: Behavioural Sciences Relevant to Oral Health Care

18.1 Health Behaviour Models and Behaviour Change 18.2 Dental Anxiety and Phobia 18.3 Psychosocial and Sociological Determinants of Oral Health

19 Chapter 19: Patient Assessment and Diagnosis

19.1 History Taking and Clinical Examination 19.2 Special Investigations and Reaching a Diagnosis

20 Chapter 20: Treatment Planning and Risk-Based Care

20.1 Treatment Planning and Sequencing 20.2 Risk Assessment, Recall Intervals and Preventive Planning

21 Chapter 21: Cariology and Caries Risk Assessment

21.1 Caries Pathogenesis and the Stephan Curve 21.2 Histopathology of Enamel and Dentinal Caries 21.3 Caries Diagnosis, ICDAS and Risk Assessment

22 Chapter 22: Operative Dentistry and Minimal Intervention

22.1 Minimal Intervention and Selective Caries Removal 22.2 Pulp Vitality Assessment and Biological Pulp Capping 22.3 Cavity Design, the C-Factor and Margin Geometry

23 Chapter 23: Endodontics

23.1 Pulp Histology and the Low-Compliance Environment 23.2 Pulpal Neurophysiology and Dentine Hypersensitivity 23.3 Pulpal and Periapical Diagnostic Terminology 23.4 Endodontic Diagnostic Testing 23.5 Access Cavity Design and Canal Configurations 23.6 Working Length Determination and Canal Preparation 23.7 Chemical Disinfection and Irrigant Activation 23.8 Medicaments, Obturation Materials and Techniques 23.9 Restoring Endodontically Treated Teeth 23.10 Endodontic Emergencies, Cracked Teeth and Root Fracture

24 Chapter 24: Periodontology

24.1 The 2018 Classification and Periodontal Health 24.2 Plaque-Induced and Non-Plaque-Induced Gingival Disease 24.3 Staging and Grading Periodontitis 24.4 Peri-Implant Disease and Systemic Risk Factors 24.5 The Basic Periodontal Examination 24.6 Simplified BPE in Children and Full Periodontal Charting 24.7 Furcation Involvement, Mobility and Occlusal Trauma 24.8 The BSP Stepwise Treatment Framework 24.9 Periodontal Instrumentation and Healing 24.10 Re-Evaluation, Endpoints and Periodontal Surgery 24.11 Crown Lengthening, Supracrestal Attachment and Supportive Care

25 Chapter 25: Fixed Prosthodontics

25.1 Biomechanical Principles of Tooth Preparation 25.2 Margin Design and the Supracrestal Attachment 25.3 Bridge Design and Resin-Bonded Bridges 25.4 Gingival Retraction, Provisionals and Temporary Cements

26 Chapter 26: Removable Prosthodontics

26.1 Removable Partial Dentures: Classification, Design and Surveying 26.2 Complete Dentures: Principles, Impressions and Jaw Registration

27 Chapter 27: Paediatric Dentistry

27.1 Primary Tooth Anatomy and Caries Management Strategies 27.2 Preformed Metal Crowns and the Hall Technique 27.3 Pulp Therapy in Primary Teeth 27.4 Extractions in the Primary Dentition 27.5 Non-Pharmacological Behaviour Management 27.6 Inhalation Sedation in Paediatric Dentistry 27.7 The Developing Dentition and Space Management 27.8 Serial Extraction and Non-Nutritive Sucking Habits

28 Chapter 28: Dental Traumatology

28.1 Trauma Assessment and Fractures of Permanent Teeth 28.2 Luxation Injuries, Avulsion and Replantation 28.3 Primary Tooth Trauma and Splinting Specifications

29 Chapter 29: Orthodontics

29.1 Extraoral Orthodontic Assessment 29.2 Intraoral Occlusal Assessment 29.3 Skeletal Pattern and Cephalometric Analysis 29.4 IOTN and NHS Treatment Eligibility 29.5 Upper Removable Appliances 29.6 Functional and Fixed Appliances 29.7 Biology of Orthodontic Tooth Movement 29.8 Orthodontic Risks and Retention

30 Chapter 30: Oral Surgery

30.1 Exodontia Biomechanics and Instrument Selection 30.2 Surgical Flap Design, Bone Removal and Suturing 30.3 Third Molar Surgery and NICE Guidance 30.4 Dry Socket and Oroantral Communication 30.5 Odontogenic Infection and Fascial Space Spread

31 Chapter 31: Oral Medicine

31.1 Recurrent Aphthous Stomatitis 31.2 Oral Candidiasis 31.3 Viral Oral Infections 31.4 Reactive Soft Tissue Lesions and the Epulides 31.5 Oral Potentially Malignant Disorders 31.6 Oral Squamous Cell Carcinoma, Urgent Referral and Biopsy

32 Chapter 32: Oral Pathology

32.1 Odontogenic and Non-Odontogenic Cysts 32.2 Odontogenic Tumours 32.3 Obstructive and Reactive Salivary Gland Disease 32.4 Salivary Gland Neoplasms

33 Chapter 33: Therapeutics and Prescribing

33.1 Local Anaesthetic Chemistry and Mechanism of Action 33.2 UK Local Anaesthetic Formulations 33.3 Vasoconstrictors, Maximum Doses and Systemic Toxicity 33.4 Analgesics for Acute Dental Pain 33.5 Antimicrobial Stewardship and First-Line Regimens 33.6 Antifungal and Antiviral Therapeutics

34 Chapter 34: Medical Emergencies in Dental Practice

34.1 The ABCDE Approach and the Emergency Drug Kit 34.2 Anaphylaxis and Acute Coronary Syndrome 34.3 Hypoglycaemia, Acute Asthma and Seizures 34.4 Syncope, Adrenal Crisis, Choking and Resuscitation

35 Chapter 35: Dental Radiology and Radiation Protection

35.1 Radiation Physics, Filtration and Collimation 35.2 Intraoral, Bitewing and Occlusal Projections 35.3 Dental Panoramic Tomography: Principles, Positioning and Errors 35.4 Lateral Cephalometry and Cone Beam CT 35.5 Systematic Reporting and Radiographic Caries Diagnosis 35.6 Radiology of Periodontal Bone Loss and Jaw Lesions 35.7 Radiographic Quality Assurance 35.8 IRR17 and IR(ME)R 2017

36 Chapter 36: Special Care Dentistry and Conscious Sedation

36.1 Special Care Dentistry, Risk Stratification and Sedation Principles 36.2 Inhalation Sedation with Nitrous Oxide 36.3 Intravenous Sedation with Midazolam 36.4 Oral Sedation and General Anaesthesia Referral

37 Chapter 37: Dental Public Health

37.1 Delivering Better Oral Health and the Fluoride Toolkit 37.2 Oral Health Epidemiology and Indices 37.3 Inequalities, Water Fluoridation and Population Prevention 37.4 NHS Dental Services, Access and Commissioning

38 Chapter 38: Communication and Interpersonal Skills

38.1 Patient Communication and Shared Decision-Making 38.2 Breaking Bad News, Complaints and the Duty of Candour 38.3 Referrals, Records and Communication with the Team

39 Chapter 39: Consent and Capacity

39.1 Valid Consent and the Montgomery Standard 39.2 The Mental Capacity Act 2005 39.3 Best Interests Decisions and Lasting Power of Attorney 39.4 Consent in Children and Young People 39.5 Safeguarding Children and Vulnerable Adults 39.6 Confidentiality, Data Protection and Lawful Disclosure

40 Chapter 40: Clinical Professionalism and the GDC

40.1 The General Dental Council and Standards Principles 1 to 4 40.2 GDC Standards: Principles 5 to 9 40.3 The GDC Fitness to Practise Process 40.4 Clinical Governance and the Audit Cycle

41 Chapter 41: Health and Safety Law in Dental Practice

41.1 Health and Safety Legislation, COSHH, RIDDOR and Sharps

42 Chapter 42: Self-Management and Professional Development

42.1 Enhanced CPD, Lifelong Learning and Reflective Practice 42.2 Managing Time, Stress and Clinical Wellbeing 42.3 Leadership, Delegation and Practice Management

9.1 Innate Mucosal Immunity and Gingival Crevicular Fluid

Key Takeaways Explain This Topic AI

Junctional epithelium has wide intercellular spaces, dual basal laminae and a turnover of only four to six days.

Beta-defensin 1 is constitutive while beta-defensins 2 and 3 are induced by microbial challenge and inflammation.

Cathelicidin LL-37 is released from the hCAP-18 precursor by proteinase 3 from neutrophils.

Papillon-Lefevre syndrome results from CTSC mutations affecting cathepsin C, impairing neutrophil serine protease activation and causing early severe periodontitis.

Last updated: September 2026

  • 1. Innate Mucosal Immunity in the Oral Cavity
  • The Epithelial Barrier: Architectural Specialisation

The oral mucosa presents three distinct gingival epithelial phenotypes, each adapted to distinct mechanical and immunological demands:

Epithelial Zone Keratinisation Intercellular Space Basal Lamina Turnover Rate

Oral Gingival Epithelium (OGE) Ortho- or parakeratinised Narrow (~1% volume) Single external basal lamina 10–14 days

  • Sulcular Epithelium (SE) Non-keratinised / parakeratinised Intermediate Single external basal lamina 8–10 days
  • Junctional Epithelium (JE) Non-keratinised Wide (~18% volume) Dual: internal (DAT) & external 4–6 days

The junctional epithelium (JE) forms the anatomical attachment between the gingiva and the calcified tooth surface (directly attached to the tooth, DAT) via hemidesmosomes and an internal basal lamina. Because its cells are oriented parallel to the tooth surface and express fewer desmosomal junctions, the intercellular spaces occupy up to 18% of the tissue volume. This permeable architecture serves as a high-flow transit corridor, facilitating the constant forward percolation of gingival crevicular fluid (GCF) into the sulcus and the reciprocal trans-epithelial migration of host immune cells toward the subgingival biofilm.

Junctional epithelial cells constitutively express intercellular adhesion molecule-1 ( ICAM-1 / CD54 ) and secrete the chemokine CXCL8 (IL-8) in response to bacterial lipopolysaccharide (LPS). This establishes an immobilized haptotactic gradient that directs migrating polymorphonuclear leukocytes (PMNs) directly into the gingival crevice.

Antimicrobial Peptides (AMPs)

Antimicrobial peptides represent ancient effector molecules synthesized by oral keratinocytes and recruited phagocytes:

Human Beta-Defensins (hBDs): Small, cationic, cysteine-rich peptides containing three intramolecular disulfide bonds.

hBD-1: Constitutively expressed by suprabasal stratified squamous cells throughout the oral mucosa, providing persistent baseline surveillance.

hBD-2 and hBD-3: Strongly inducible in response to pro-inflammatory stimuli (TNF-α, IL-1β) and Gram-negative bacterial lipopolysaccharide via Toll-like receptors (TLR2 and TLR4). They disrupt microbial cell membranes via pore formation and function as chemoattractants for immature dendritic cells and memory T lymphocytes through chemokine receptor CCR6.

Alpha-Defensins (Human Neutrophil Peptides HNP-1 to HNP-4): Stored in the azurophilic granules of neutrophils and released directly into the gingival crevice during degranulation or NETosis.

Cathelicidin (LL-37 / hCAP-18): Synthesised as an inactive precursor (hCAP-18) and cleaved into the active 37-amino acid peptide LL-37 by neutrophil proteinase 3 . LL-37 exerts broad-spectrum bactericidal activity against subgingival anaerobes, neutralises bacterial LPS to curb endotoxic shock, and promotes re-epithelialisation.

Important

Clinical Relevance — Papillon-Lefèvre Syndrome: Papillon-Lefèvre syndrome is an autosomal recessive disorder caused by loss-of-function mutations in the CTSC gene encoding cathepsin C (dipeptidyl peptidase I). Cathepsin C is required to remove the N-terminal pro-peptides to activate neutrophil serine proteases, including proteinase 3, elastase, and cathepsin G. In the absence of functional proteinase 3, hCAP-18 cannot be processed into active LL-37. This selective molecular failure leads to catastrophic, prepubertal periodontitis resulting in early loss of both deciduous and permanent dentitions, combined with severe palmoplantar hyperkeratosis.

Gingival Crevicular Fluid (GCF) Dynamics

In absolute health, GCF is an interstitial transudate produced at minimal rates (0.2–0.5 µL/hour). With the onset of biofilm-induced subclinical inflammation, microvascular permeability within the gingival plexus increases dramatically, transforming GCF into an inflammatory exudate whose flow rate increases more than five-fold (>1.5–3.5 µL/hour).

GCF fulfills dual protective roles:

Mechanical flushing: Continual outward hydrokinetic flow retards the inward penetration of non-adherent planktonic bacteria into the subgingival pocket.

Biochemical and cellular defence delivery: GCF delivers serum-derived complement proteins (C3, C4, C5), specific immunoglobulins (predominantly IgG1 and IgG2 subclasses), transferrin, lactoferrin, and active host leukocytes—of which viable neutrophils constitute over 90–95%.

The Junctional Epithelium as a Controlled Weak Point

The junctional epithelium is where the body's surface is deliberately interrupted to let a hard tissue through, and almost everything about periodontal disease follows from that compromise. It is non-keratinised, has wide intercellular spaces and comparatively few desmosomes, and it attaches to the tooth by a hemidesmosome–basal lamina complex. Those features make it permeable in both directions: bacterial products pass inwards, and neutrophils and gingival crevicular fluid pass outwards. Turnover is rapid — of the order of four to six days — which is itself a defence, because infected superficial cells are shed into the sulcus. The examinable consequence is that the junctional epithelium is simultaneously the principal portal of entry for periodontal pathogens and the principal exit route for the host's cellular defence.

Gingival Crevicular Fluid as a Diagnostic Window

Gingival crevicular fluid is a serum transudate in health and becomes an inflammatory exudate in disease, and its volume increases in proportion to the degree of inflammation. Because it carries host enzymes and mediators, it has been extensively investigated as a diagnostic sample — matrix metalloproteinase-8, interleukin-1β and aspartate aminotransferase are the markers most often cited. The examinable caution is that no gingival crevicular fluid marker has replaced probing and radiographs in routine practice; site-specific diagnosis of periodontitis in the UK remains clinical, based on interdental clinical attachment loss and radiographic bone loss.

Sections you finish are checked off in the contents.

  • Up Next
  • 9.2 Cellular Immunity in the Periodontium
  • Continue learning